BCORL1, POF1B, and USP9X copy number variation in women with idiopathic diminished ovarian reserve
- PMID: 38995507
- PMCID: PMC11405560
- DOI: 10.1007/s10815-024-03185-8
BCORL1, POF1B, and USP9X copy number variation in women with idiopathic diminished ovarian reserve
Abstract
Purpose: To analyze the copy number variation (CNV) in the X-linked genes BCORL1, POF1B, and USP9X in idiopathic diminished ovarian reserve (DOR).
Methods: This case-control study included 47 women, 26 with DOR and 21 in the control group. Age, weight, height, BMI, and FSH level were evaluated, as well as antral follicle count (AFC), oocyte retrieval after controlled ovarian stimulation, and metaphase II (MII) oocytes. The CNVs of BCORL1, USP9X, and POF1B genes were measured by quantitative real time PCR (qPCR) using two reference genes, the HPRT1 (X-linked) and MFN2 (autosomal). Protein-protein interaction network and functional enrichment analysis were performed using the STRING database.
Results: The mean age was 36.52 ± 4.75 in DOR women and 35.38 ± 4.14 in control. Anthropometric measures did not differ between the DOR and control groups. DOR women presented higher FSH (p = 0.0025) and lower AFC (p < .0001), oocyte retrieval after COS (p = 0.0004), and MII oocytes (p < .0001) when compared to the control group. BCORL1 and POF1B did not differ in copy number between DOR and control. However, DOR women had more copies of USP9X than the control group (p = 0.028).
Conclusion: The increase in the number of copies of the USP9X gene may lead to overexpression in idiopathic DOR and contribute to altered folliculogenesis and oocyte retrieval.
Keywords: Copy number variation; Genomic instability; Aging; DOR; Ovarian failure.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
The authors declare no competing interests.
Figures




Similar articles
-
Safety and effectiveness of controlled ovarian stimulation and oocyte retrieval during prepubertal and peripubertal period.J Assist Reprod Genet. 2024 Oct;41(10):2823-2830. doi: 10.1007/s10815-024-03262-y. Epub 2024 Sep 19. J Assist Reprod Genet. 2024. PMID: 39297990
-
Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI).Cochrane Database Syst Rev. 2018 Feb 1;2(2):CD012693. doi: 10.1002/14651858.CD012693.pub2. Cochrane Database Syst Rev. 2018. Update in: Cochrane Database Syst Rev. 2024 Jan 4;1:CD012693. doi: 10.1002/14651858.CD012693.pub3. PMID: 29388198 Free PMC article. Updated.
-
Randomized controlled trial to evaluate the impact of follicle priming on IVM outcomes in women with polycystic ovaries: CFA versus FSH-B.Hum Reprod. 2025 Jun 1;40(6):1127-1137. doi: 10.1093/humrep/deaf053. Hum Reprod. 2025. PMID: 40194780 Clinical Trial.
-
Nicotinamide mononucleotide supplementation improves oocyte developmental competence in different ovarian damage conditions.Am J Obstet Gynecol. 2025 Aug;233(2):112.e1-112.e20. doi: 10.1016/j.ajog.2025.02.006. Epub 2025 Feb 7. Am J Obstet Gynecol. 2025. PMID: 39923879
-
Efficacy of intra-ovarian injection of autologous platelet-rich plasma in women with poor responders: a systematic review and meta-analysis.Arch Gynecol Obstet. 2024 Jun;309(6):2323-2338. doi: 10.1007/s00404-024-07442-0. Epub 2024 Apr 8. Arch Gynecol Obstet. 2024. PMID: 38589612
Cited by
-
Live bacteria found in gastric cancer tumor tissue.Front Microbiol. 2025 Jun 18;16:1591735. doi: 10.3389/fmicb.2025.1591735. eCollection 2025. Front Microbiol. 2025. PMID: 40606178 Free PMC article.
-
Searching for the 'X' factor: investigating the genetics of primary ovarian insufficiency.J Ovarian Res. 2024 Nov 28;17(1):238. doi: 10.1186/s13048-024-01555-5. J Ovarian Res. 2024. PMID: 39609914 Free PMC article. Review.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous